Edition:
United Kingdom

IPCA Laboratories Ltd (IPCA.NS)

IPCA.NS on National Stock Exchange of India

667.35INR
23 May 2018
Change (% chg)

Rs5.75 (+0.87%)
Prev Close
Rs661.60
Open
Rs660.10
Day's High
Rs682.70
Day's Low
Rs660.10
Volume
61,848
Avg. Vol
242,909
52-wk High
Rs760.00
52-wk Low
Rs400.00

Chart for

About

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS... (more)

Overall

Beta: -0.18
Market Cap(Mil.): Rs65,743.43
Shares Outstanding(Mil.): 126.20
Dividend: 1.00
Yield (%): 0.19

Financials

  IPCA.NS Industry Sector
P/E (TTM): 88.05 30.95 32.75
EPS (TTM): 5.92 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-India's IPCA Labs Dec-Qtr Profit More Than Doubles

* DEC QUARTER PROFIT FROM CONTINUING OPERATIONS 1.06 BILLION RUPEES VERSUS PROFIT 413.8 MILLION RUPEES YEAR AGO

07 Feb 2018

BRIEF-Ipca Laboratories' Units To Acquire Pisgah Labs For $9.65 Mln​​

* SAYS ‍ACQUISITION OF 100 PCT SHARE CAPITAL OF PISGAH LABS INC., NORTH CAROLINA, USA BY COMPANY'S SUBSIDIARIES

17 Jan 2018

Earnings vs. Estimates